Smith Andrew Alasdair Insider Trading -- Recent SEC Form 4 Transactions

Smith Andrew Alasdair (CIK 1309614) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-08). Recent activity: Buy MDCX (735,294 shares). Source: SEC Form 4.

DateCompanyRoleTypeSharesValue
2026-09-08Medicus Pharma Ltd. (MDCX)Chief Operating OfficerBuy735,294$125,368

Source: SEC Form 4 filings · as of 2026-09-08